STARING at yet another pregnancy test, Erica Coronado was thrilled but terrified. The 36-year-old had given up hope of a baby after two years of trying and the agony of a stillbirth. So seeing two ...

Bagsværd, Denmark, 10 June – Novo Nordisk today announced that new data from its industry-leading portfolio in metabolic and cardiovascular health will be showcased at the upcoming American Diabetes ...

In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

Adolescents face significant barriers to obesity medication access, despite a surge in prescriptions. Discover the ...

Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...

The UK's MHRA have issued a warning to people on birth control who may also be taking drugs like Ozempic, Wegovy or Mounjaro ...

FDA seizes hundreds of fake Ozempic units from US supply after Novo Nordisk alerts regulators to counterfeit semaglutide ...

Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - ...

Doctors from around the world recently teamed up to study a new pill that could help people with type 2 diabetes manage their ...